Literature DB >> 33096081

Autophosphorylation of EGFR at Y954 Facilitated Homodimerization and Enhanced Downstream Signals.

Ovia M Thirukkumaran1, Malgorzata Kluba1, Johan Hofkens2, Hideaki Mizuno3.   

Abstract

Asymmetric dimer formation of epidermal growth factor receptor (EGFR) is crucial for EGF-induced receptor activation. Even though autophosphorylation is important for activation, its role remains elusive in the context of regulating dimers. In this study, employing overlapping time series analysis to raster image correlation spectroscopy (RICS), we observed time-dependent transient dynamics of EGFR dimerization and found EGFR kinase activity to be essential for dimerization. As a result of which, we hypothesized that phosphorylation could influence dimerization. Evaluating this point, we observed that one of the tyrosine residues (Y954) located in the C-terminal lobe of the activator kinase domain was important to potentiate dimerization. Functional imaging to monitor Ca2+ and ERK signals revealed a significant role of Y954 in influencing downstream signaling cascade. Crucial for stabilization of EGFR asymmetric dimer is a "latch" formed between kinase domains of the binding partners. Because Y954 is positioned adjacent to the latch binding region on the kinase domain, we propose that phosphorylation strengthened the latch interaction. On the contrary, we identified that threonine phosphorylation (T669) in the latch domain negatively regulated EGFR dimerization and the downstream signals. Overall, we have delineated the previously anonymous role of phosphorylation at the latch interface of kinase domains in regulating EGFR dimerization.
Copyright © 2020 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33096081      PMCID: PMC7732767          DOI: 10.1016/j.bpj.2020.10.008

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  39 in total

1.  Epidermal growth factor (EGF) receptor kinase-independent signaling by EGF.

Authors:  T B Deb; L Su; L Wong; E Bonvini; A Wells; M David; G R Johnson
Journal:  J Biol Chem       Date:  2001-02-05       Impact factor: 5.157

2.  Raster image correlation spectroscopy in live cells.

Authors:  Molly J Rossow; Jennifer M Sasaki; Michelle A Digman; Enrico Gratton
Journal:  Nat Protoc       Date:  2010-10-14       Impact factor: 13.491

3.  Measuring fast dynamics in solutions and cells with a laser scanning microscope.

Authors:  Michelle A Digman; Claire M Brown; Parijat Sengupta; Paul W Wiseman; Alan R Horwitz; Enrico Gratton
Journal:  Biophys J       Date:  2005-05-20       Impact factor: 4.033

4.  EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization.

Authors:  Kathryn M Ferguson; Mitchell B Berger; Jeannine M Mendrola; Hyun Soo Cho; Daniel J Leahy; Mark A Lemmon
Journal:  Mol Cell       Date:  2003-02       Impact factor: 17.970

Review 5.  The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities.

Authors:  Y Yarden
Journal:  Eur J Cancer       Date:  2001-09       Impact factor: 9.162

6.  Epidermal growth factor.

Authors:  G Carpenter; C M Stoscheck; A M Soderquist
Journal:  Ann N Y Acad Sci       Date:  1982-12-10       Impact factor: 5.691

7.  Intramolecular interaction between phosphorylated tyrosine-783 and the C-terminal Src homology 2 domain activates phospholipase C-gamma1.

Authors:  Benoit Poulin; Fujio Sekiya; Sue Goo Rhee
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-11       Impact factor: 11.205

Review 8.  Epidermal growth factor receptor: mechanisms of activation and signalling.

Authors:  Robert N Jorissen; Francesca Walker; Normand Pouliot; Thomas P J Garrett; Colin W Ward; Antony W Burgess
Journal:  Exp Cell Res       Date:  2003-03-10       Impact factor: 3.905

9.  Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment.

Authors:  Natalia Jura; Nicholas F Endres; Kate Engel; Sebastian Deindl; Rahul Das; Meindert H Lamers; David E Wemmer; Xuewu Zhang; John Kuriyan
Journal:  Cell       Date:  2009-06-26       Impact factor: 41.582

10.  ErbB1 dimerization is promoted by domain co-confinement and stabilized by ligand binding.

Authors:  Shalini T Low-Nam; Keith A Lidke; Patrick J Cutler; Rob C Roovers; Paul M P van Bergen en Henegouwen; Bridget S Wilson; Diane S Lidke
Journal:  Nat Struct Mol Biol       Date:  2011-10-23       Impact factor: 15.369

View more
  2 in total

Review 1.  PBK/TOPK: An Effective Drug Target with Diverse Therapeutic Potential.

Authors:  Hai Huang; Mee-Hyun Lee; Kangdong Liu; Zigang Dong; Zeayoung Ryoo; Myoung Ok Kim
Journal:  Cancers (Basel)       Date:  2021-05-06       Impact factor: 6.639

2.  Versatile and Robust Method for Antibody Conjugation to Nanoparticles with High Targeting Efficiency.

Authors:  Indra Van Zundert; Maria Bravo; Olivier Deschaume; Pierre Cybulski; Carmen Bartic; Johan Hofkens; Hiroshi Uji-I; Beatrice Fortuni; Susana Rocha
Journal:  Pharmaceutics       Date:  2021-12-14       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.